HELIOS-A: A Study of Vutrisiran (ALN-TTRSC02) in Patients With Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis)
Clinical trial NCT03759379 · COMPLETED
Trial details
- NCT number
- NCT03759379
- Sponsor
- Alnylam Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-14
- Primary completion
- 2020-11-10
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.